DÄ internationalArchiveReferences

Review article

Phosphate Additives in Food

Dtsch Arztebl Int 2012; 109(4): 49-55. DOI: 10.3238/arztebl.2012.0049

Ritz, E; Hahn, K; Ketteler, M; Kuhlmann, M K; Mann, J

1.Sullivan C, et al.: Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 2009; 301: 629–35. CrossRef MEDLINE
2.Block GA, et al.: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. JASN 2004; 15: 2208–18. CrossRef MEDLINE
3.Kestenbaum B, et al.: Serum phosphate levels and mortality risk among people with chronic kidney disease. JASN 2005; 16: 520–8. CrossRef MEDLINE
4.KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009: S1–130. MEDLINE
5.Noori N, et al.: Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. CJASN 2010; 5: 683–92. MEDLINE
6.Foley RN, et al.: Serum phosphorus levels associate with coronary atherosclerosis in young adults. JASN 2009; 20: 397–404. CrossRef MEDLINE
7.Dhingra R, et al.: Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167: 879–85. CrossRef MEDLINE
8.Tonelli M, et al.: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005; 112: 2627–33. CrossRef MEDLINE
9.Gutierrez OM, et al.: Low socioeconomic status associates with higher serum phosphate irrespective of race. JASN 2010; 21: 1953–60. CrossRef MEDLINE
10.Berndt T, Kumar R: Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda) 2009; 24: 17–25. CrossRef MEDLINE
11.Liu S, Quarles LD: How fibroblast growth factor 23 works. JASN 2007; 18: 1637–47. CrossRef MEDLINE
12.Shimada T, et al.: Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 2004; 113: 561–8. MEDLINE
13.Wetmore JB, Quarles LD: Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift? Nat Clin Pract Nephrol 2009; 5: 24–33. CrossRef MEDLINE
14.Kuro-o M, et al.: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997; 390: 45–51. CrossRef MEDLINE
15.Kuro-o M: A potential link between phosphate and aging—lessons from Klotho-deficient mice. Mech Ageing Dev 2010; 131: 270–5. CrossRef MEDLINE
16.Giachelli CM: The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75: 890–7. CrossRef MEDLINE
17.Shroff RC, et al.: Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. JASN 2010; 21: 103–12. CrossRef MEDLINE
18.Shuto E, et al.: Dietary phosphorus acutely impairs endothelial function. JASN 2009; 20: 1504–12. CrossRef MEDLINE
19.Bohn L, Meyer AS, Rasmussen SK: Phytate: impact on environment and human nutrition. A challenge for molecular breeding. J Zhejiang Univ Sci B 2008; 9: 165–91. CrossRef MEDLINE
20.Lei XG, Porres JM: Phytase enzymology, applications, and biotechnology. Biotechnol Lett 2003; 25: 1787–94. CrossRef MEDLINE
21.Kalantar-Zadeh K, et al.: Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. CJASN 2010; 5: 519–30. MEDLINE
22.Sherman RA, Mehta O: Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis. CJASN 2009; 4: 1370–3. MEDLINE
23.Tonelli M, Pannu N, Manns B: Oral phosphate binders in patients with kidney failure. NEJM 2010; 362: 1312–24. CrossRef MEDLINE
24.Haut LL, et al.: Renal toxicity of phosphate in rats. Kidney Int 1980; 17: 722–31. CrossRef MEDLINE
25.Klaus D, Hoyer J, Middeke M: Salt restriction for the prevention of cardiovascular disease. Dtsch Arztebl Int 2010; 107(26): 457–62. VOLLTEXT
e1.Uribarri J: Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake. Semin Dial 2007; 20: 295–301. CrossRef MEDLINE
e2.Ohnishi M, Razzaque MS: Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 2010; 24: 3562–71. CrossRef MEDLINE
e3.Dhingra R, et al.: Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community. Eur J Heart Fail 2010; 12: 812–8. MEDLINE
e4.Prie D, Urena Torres P, Friedlander G: Latest findings in phosphate homeostasis. Kidney Int 2009; 75: 882–9. MEDLINE
e5.Martin KJ, Gonzalez EA: Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat? Clin J Am Soc Nephrol 2011; 6: 440–6. CrossRef MEDLINE
e6.Stubbs JR, et al.: Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 2007; 18: 2116–24. MEDLINE
e7.Moe SM, et al.: Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 2002; 61: 638–47. MEDLINE
e8.Kayne LH, et al.: Analysis of segmental phosphate absorption in intact rats. A compartmental analysis approach. J Clin Invest 1993; 91: 915–22. MEDLINE
e9.Calvo MS, Park YK: Changing phosphorus content of the U.S. diet: potential for adverse effects on bone. J Nutr 1996; 126(4 Suppl): 1168S–80S. MEDLINE
e10.Alfrey AC: The role of abnormal phosphorus metabolism in the progression of chronic kidney disease and metastatic calcification. Kidney Int Suppl 2004: S13–7. MEDLINE